-
Americas
-
Asia & Oceania
-
A-I
J-Z
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Regions
-
Americas
-
Asia & Oceania
-
Europe
-
Middle East & Africa
-
Americas
-
Asia & Oceania
-
Europe
Europe
- Adriatic
- Belgium
- Bulgaria
- Czech Republic
- Deutschland
- España
- France
- Greece
- Hungary
- Ireland
- Israel
- Italia
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more -
Middle East & Africa
EMEA Thought Leadership
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
FEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI®
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESBlog
DIA Recap: Monday, June 15
Jun 15, 2020
During this critical moment in global healthcare, the show must go on for the largest and longest-running life sciences industry event— just virtually!
IQVIA is pleased to be a leading sponsor of 2020 DIA Global Annual Meeting this week, where our experts will be leading a variety of discussions to help the industry tackle complex challenges and brainstorm ways to continue bringing much-needed therapies to patients regardless of potential roadblocks.
During this first full day of programming, several IQVIA leaders articulated actionable insights to help clinical trial sponsors and the broader industry continue studying disease and driving innovation during the COVID-19 crisis and beyond.
Here’s a brief recap of their Innovation Theater presentations, which are available to DIA conference registrants to view on demand for the next 60 days.
- During “COVID-19 Disruption Provides a Pivotal Opportunity to Accelerate Patient Engagement Innovation,” Erica Prowisor, global head, Recruitment and Retention for IQVIA Research and Development Solutions, discussed IQVIA’s strategies for maintaining trial continuity in a complicated new era of clinical research. Recognizing this time in history as a unique opportunity to accelerate patient-centric innovation, Prowisor discussed how IQVIA is laser-focused on mobilizing its wide breadth of data, technology, analytics and expertise to unite all stakeholders (e.g., sponsors, site teams, and patients) and rethink how to deliver more agile recruitment strategies. Through IQVIA’s Direct-to-Patient Recruitment solution, the team is using an innovative, holistic digital approach, to drive productivity to safely identify, recruit and retain the right patients for each trial while reducing the burden on site and study teams.
- More than ever, patients want know about their treatment and should be treated as valued partners in clinical development. In the “Digital Patient Experience/Virtual Trials” presentation, IQVIA’s MaryAnne Rizk, senior vice president, Research and Development Solutions Digital Strategy, and Jean Paty, vice president, Patient Centered Sciences, spoke about the importance of creating a patient-centric experience from molecule to market for all stakeholders. Today, IQVIA offers a new SaaS-based cloud platform called Orchestrated Clinical Trials to produce an uninterrupted flow of data-driven evidence to quickly close the gap between data collection and decision-making and allow study teams and sponsors to better understand and respond to patient needs.
On Sunday, as part of the preconference course “Real World Evidence: The Evolving Landscape of Regulators, Data, and Integrated Use,” IQVIA Real World Solutions Chief Scientific Officer Nancy Dreyer and Matthew Reynolds, vice president, Real World Evidence, shared how real-world evidence is used to generate actionable insights in major markets globally. While evidence generation primarily focuses on regulatory use, Nancy and Matthew, alongside Amgen leaders Brian Bradbury and Gillis Carrigan, explained key epidemiological design principles critical to interpreting the quality and validity of real-world evidence studies as identified by the U.S. Food and Drug Administration in late 2019. The course also noted the current status of the FDA’s guidance on when real world studies will sufficiently meet regulatory evidence requirements.
It’s been a great start to DIA 2020! As informative and exciting discussions continue this week, we will continue providing daily roundups of the sessions highlighting IQVIA and industry experts’ discussions on ways to improve health globally.
Already attending DIA? We invite you to visit the IQVIA virtual booth or contact us here to schedule a meeting with one of our experts and learn more about the ways IQVIA is driving healthcare forward.